246710 — T&R Biofab Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual income statement for T&R Biofab Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	6,805	3,235	5,755	5,199	4,874
Cost of Revenue
Gross Profit	2,659	-212	1,542	1,077	2,132
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	12,314	13,662	13,798	18,743	13,643
Operating Profit	-5,509	-10,428	-8,043	-13,544	-8,769
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-5,604	-11,083	-10,337	-13,419	-7,679
Provision for Income Taxes
Net Income After Taxes	-5,604	-11,083	-10,337	-13,419	-7,679
Net Income Before Extraordinary Items
Net Income	-5,604	-11,083	-10,337	-13,419	-7,679
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-5,604	-11,083	-10,337	-13,419	-7,679
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-334	-613	-728	-594	-566
Dividends per Share